510(k) Report

FDA product code · Pathology

Software Algorithm Device To Assist Users In Digital Pathology

QPNClass II21 CFR 864.3750510(k) required2 decisions since 20210 recalls

2 FDA decisions since 2021. 510(k) reviews decided 2021–2025 took a median of 267 days (half between 267 and 267). No recall names this code. The most-cited predicate is DEN200080, named by 1 later device.

A software algorithm device to assist users in digital pathology is an in vitro diagnostic device intended to evaluate acquired scanned pathology whole slide images. The device uses software algorithms to provide information to the user about presence, location, and characteristics of areas of the image with clinical implications. Information from this device is intended to assist the user in determining a…

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, pathology panel

Twenty years of QPN at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · QPN

1in 2025

2021: 12025: 1
2007high 1 (2021) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QPN

Too few QPN 510(k)s in any year since 2007 to give a median.

Recalls per year · QPN

No recall names QPN since 2007.

Adverse event reports per year · QPN

No MAUDE report names QPN since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20211—00
20220—00
20230—00
20240—00
20251—00
20260—0—
FIG. 1 — QPN by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in QPN? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report